Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Transcutaneous Vagus Nerve Stimulation (tVNS) for Improved Recovery After Exertion.

NCT: NCT06510985 · ACTIVE_NOT_RECRUITING

NCT IDNCT06510985
StatusACTIVE_NOT_RECRUITING
Start Date2024-07-19
Completion2027-05
SponsorUniversity Hospital Tuebingen (OTHER)
First posted
Last updated

Brief Summary

Widespread infection with SARS-CoV-2 has resulted in millions of people having Post-COVID. Post-COVID is a complex, non-monolithic disease with diverse clinical manifestations. Symptoms range from fatigue, brain fog, muscle aches and shortness of breath, affecting multiple organ systems simultaneously. To directly address this multi-organ component of Post-COVID, innovative treatment methods are urgently needed. One potential treatment that we will investigate in our study, is the intervention via the vagus nerve, as the cranial nerve plays a central role in communication between the body and the brain and influences targeted behavior. This innovative approach is based on our clinically relevant findings regarding the effects where acute tVNS increased the level of effort (Neuser et al., 2020; Ferstl et al., 2021), specifically targeting a key symptom of Post-COVID. In the proposed study, the investigators aim to investigate the effectiveness of transcutaneous vagus nerve stimulation (tVNS) as a non-invasive, self-administered treatment for Post-COVID symptoms at home. To evaluate the clinically relevant effects of repeated taVNS application (high-intensity stimulation), the investigators will employ a randomized cross-over design to investigate stimulation-induced changes in fatigue, depression and motivation to work for reward compared to low-intensity stimulation and to a control group.

Frequently Asked Questions

What is Transcutaneous Vagus Nerve Stimulation (tVNS) for Improved Recovery After Exertion.?

Transcutaneous Vagus Nerve Stimulation (tVNS) for Improved Recovery After Exertion. is a clinical trial registered under NCT06510985. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT06510985?

The current status of NCT06510985 (Transcutaneous Vagus Nerve Stimulation (tVNS) for Improved Recovery After Exertion.) is: ACTIVE_NOT_RECRUITING.

When did Transcutaneous Vagus Nerve Stimulation (tVNS) for Improved Recovery After Exertion. start?

Transcutaneous Vagus Nerve Stimulation (tVNS) for Improved Recovery After Exertion. started on 2024-07-19.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.